March 13, 2026 – Abbott proclaims outcomes from the FreeDM2 randomized managed trial (RCT) displaying that folks utilizing FreeStyle Libre steady glucose monitoring (CGM) know-how had higher glucose outcomes than these utilizing conventional fingersticks. Enhancements had been achieved by way of participant-led self-management guided by real-time CGM insights. The findings had been offered on the nineteenth Worldwide Convention on Superior Applied sciences & Remedies for Diabetes (ATTD).

About 63 million folks worldwide depend on insulin to handle kind 2 diabetes, however real-world analysis exhibits that solely 18% to 30% of those that use basal insulin attain their HbA1c targets. This hole contributes to an estimated $217 billion in annual diabetes care prices, indicating that hundreds of thousands of individuals nonetheless want assist to realize wholesome glucose ranges. The FreeDM2 randomized, managed trial is designed to find out whether or not real-time steady glucose monitoring can assist folks taking basal insulin enhance their glucose administration.

Proceed studying